That combination, fast and non-specific, is exactly why the test is used as a starting point rather than an answer. What follows covers the common reasons it gets ordered, what the number can support, and what it cannot settle on its own.
C-reactive protein, or CRP, is a protein released by the liver as part of the body's acute phase response, and its production is driven largely by interleukin 6 signalling 1. It is measured from an ordinary blood sample and reported in mg/L. A typical lab reference range for standard CRP is 0 to 3 mg/L. FitScript's optimal range is 0 to 1 mg/L, and optimal ranges are optimization targets rather than diagnostic cut-offs. Reference ranges vary by lab, age and sex, so read the range printed on your own report. The marker itself, the assay and how to interpret a value in depth are covered on the C-Reactive Protein guide. This page stays with the question of why a clinician orders the test in the first place.
They are trying to find out whether an inflammatory response is switched on right now, and roughly how strong it is. The liver increases CRP output within hours of an inflammatory stimulus and output falls again as the stimulus resolves, which is what makes the protein a useful acute phase marker 2. The number behaves like a thermometer for inflammation. It is loud about intensity and silent about location.
CRP is not only a readout. It takes part in host defence by binding phosphocholine exposed on damaged cell membranes and on some microbial surfaces, which helps flag those targets for complement activation and clearance 2. It belongs to the pentraxin family, a group of proteins conserved across a wide span of species as part of innate immunity 3. That ancient role is the reason the response is so general. Almost anything that damages tissue or activates innate immune signalling can lift the number.
In day to day practice, that general signal gets used in three ways. First, to support or weaken a suspicion raised by symptoms and examination, usually when infection or significant tissue inflammation is on the list of possibilities. Second, to follow something already identified, by repeating the test and watching the direction of travel. Third, to add context to longer term risk in a person who is not acutely unwell, using the high-sensitivity version of the assay. Those three purposes look similar on a request form and are read very differently.
Because a sharp rise supports the picture of an active infection or significant tissue inflammation, and a low value makes a large, established bacterial process less likely, though neither finding is conclusive on its own. The test is quick, inexpensive and available almost everywhere, so it is often drawn in the same tube run as a blood count when someone presents feeling unwell.
The mechanism behind that usefulness is direct. CRP binds structures exposed on damaged cells and on certain bacterial surfaces and helps recruit complement to clear them, so the liver's output scales with the size of the insult 2. A large bacterial process tends to produce a large rise. A mild viral illness often produces a smaller one. The overlap between those two patterns is wide enough that the number alone never decides the question.
Timing matters as much as the value. Very early in an illness the liver may not yet have responded, so a sample drawn in the first hours can read far lower than the clinical picture suggests. That is one reason a clinician may order a repeat rather than act on a single reassuring number. Age matters too. Studies suggest that CRP measurement supports the assessment of older patients hospitalised with acute infection, while still needing to be read against the clinical picture and other conditions present 4.
CRP sits alongside the history, the examination, imaging and, where relevant, cultures. It narrows the field. It does not name the organism or the organ.
Because the same test, repeated, shows whether inflammation is settling, holding steady or climbing, and that direction carries more information than any single value. Once a condition has been identified, the person's own earlier results become the comparison that matters, not the population reference range.
This is why CRP appears so often on monitoring request forms. In inflammatory joint, bowel and vascular conditions, a rising value can prompt a clinician to look for a flare before the picture is obvious, and a falling value supports the impression that things are quietening. After surgery, CRP normally rises as part of the healing response and then comes down. A trend that fails to come down, or turns upward again after falling, is the kind of pattern that prompts a closer look rather than a conclusion.
The same logic applies when someone is being assessed for an unexplained inflammatory process over weeks. One number on one day says little. Three numbers over three weeks describe a shape. A clinician sets the interval, because the right gap depends entirely on what is being followed and how fast it is expected to move.
None of this makes CRP a measure of how someone feels. People can feel much better while the number is still falling, and occasionally feel poorly while the number is unremarkable. The trend is one input into a judgement that still rests on the person in front of the clinician.
High-sensitivity CRP measures the same protein with an assay that reads accurately at the low end of the range, where the standard test simply reports a value below its detection floor. It is ordered to look at small, persistent differences in baseline inflammation rather than to catch an acute illness.
The usual reason is cardiovascular risk context. Higher CRP is associated with cardiovascular risk 5, and research suggests CRP may take a more active part in vascular inflammation rather than only reporting it from the sidelines 5. That is why the result is read next to lipids, blood pressure, glucose markers and family history, as one more piece of a risk picture rather than a verdict.
| Feature | Standard CRP | High-sensitivity CRP |
|---|---|---|
| Protein measured | C-reactive protein | C-reactive protein, the same molecule |
| Range it reads well | Moderate to high values seen in acute illness | Low values near the bottom of the range |
| Usual reason for ordering | Suspected infection, injury, inflammatory flare, post-operative monitoring | Longer term risk context in someone who is not acutely unwell |
| How it is read | Size of the rise and the trend over days | Small, steady differences, usually confirmed on a repeat |
| Effect of a recent cold or injury | Expected, and part of what is being looked for | Confounds the result, so testing is usually deferred |
Timing is the practical catch. An acute illness, a dental infection or a hard training block can lift CRP far above its usual baseline, which swamps the subtle differences the high-sensitivity assay exists to detect. For that reason the test is typically drawn when a person is well, and often repeated on a separate occasion before much weight is placed on it. A clinician decides when and how often, and what the result means for that individual.
Because an unexplained pattern of fatigue, aching, weight loss, night sweats or low grade fever raises a basic question, whether any inflammatory process is present at all, and CRP answers that quickly and cheaply. It is a triage test in that setting, not a diagnostic one.
Think of it as a fork in the investigative road. A clearly raised value in someone with vague symptoms tends to push the work-up toward infection, inflammatory and tissue-damage causes, and often toward imaging. A low value in the same person shifts attention toward explanations that do not involve a strong inflammatory response, which is a long list including sleep, nutrition, thyroid and mood related causes. Neither direction is a conclusion. Both change what gets looked at next.
This is also why CRP is sometimes ordered when nothing specific is suspected. It costs little, turns around fast and adds one axis of information to an otherwise open picture. The downside of that convenience is that mildly raised values turn up often in people with no identifiable illness, which is precisely why a clinician repeats the test or widens the panel before drawing any line. A mildly raised result is better described as suboptimal or outside the standard range than as a finding that explains symptoms.
Because CRP is non-specific by design. The same modest elevation can come from a chest infection, a sprained ankle, a dental abscess, recovery from surgery, an autoimmune flare, or low grade inflammation linked to body composition and metabolic health. The liver responds to the signal, not to the diagnosis.
The signalling itself is less tidy than the word inflammation suggests. Research suggests that interleukin 6 and CRP carry roles beyond signalling inflammation, including functions in metabolic and other physiological processes, which is one reason a raised value is not automatically a marker of disease activity 6. Two people can share the same number for entirely different reasons.
So a clinician reads CRP in company. The history explains what has happened recently. The examination localises. A blood count, kidney and liver panel, and other markers fill in the surrounding picture. Imaging answers where. Cultures answer what. CRP answers how much and, when repeated, which way.
That is also the honest answer to a common worry. A result slightly above the reference range, in someone who feels well and had a cold two weeks ago, is a different object from the same number in someone with three weeks of fever. The value is identical. The meaning is not.
It cannot name a condition, locate the problem, or describe how unwell someone feels. Those limits are worth stating plainly, because the test is often over-read.
What it does well is quantify an active inflammatory response and, on repeat testing, show which way that response is heading. Used for that, it earns its place on most request forms. Used as a standalone verdict, it misleads in both directions.
Plenty, which is part of why context matters so much when a result is interpreted. Most of the following are ordinary rather than concerning, and a clinician will ask about them before reading much into a mildly raised value.
None of these makes a raised result meaningless. They change how much weight it carries. If you are having a high-sensitivity CRP drawn for risk context rather than for an acute problem, it is reasonable to ask whether a recent illness or a hard training week should push the appointment back a couple of weeks. That decision sits with the person ordering the test.
Yes, in two separate ways. Research suggests that CRP concentrations tend to be higher on average in older adults, reflecting the low grade chronic inflammatory state that accompanies ageing, and that higher levels in older people are associated with age related conditions and decline 7. A value that would stand out in a younger adult can be closer to the local norm later in life.
The second way concerns acute illness. Studies suggest that CRP remains informative in older patients hospitalised for acute infection, while also showing that the result has to be interpreted alongside coexisting conditions and the overall clinical presentation rather than against a single universal threshold 4. Older adults more often present without a clear fever or a classic symptom pattern, so an objective marker helps, but it does not simplify the judgement.
The practical consequence is that the same number can prompt different responses at different ages. This is also why FitScript's optimal range, like any optimization target, is a direction of travel rather than a line that divides health from illness. Your clinician reads your value against your history, your age and your previous results.
CRP is rarely drawn alone, because its value comes from the company it keeps. The exact combination depends on the question being asked.
| Marker | What it adds next to CRP |
|---|---|
| Erythrocyte sedimentation rate (ESR) | A slower moving inflammation marker that rises and falls over weeks, so the pair can distinguish a recent event from a longer standing one |
| Complete blood count | White cell numbers and pattern, platelet count and anaemia, which help separate infection from other inflammatory causes |
| Ferritin | Iron storage protein that also behaves as an acute phase reactant, so it is read with CRP to avoid misreading iron status |
| Comprehensive metabolic panel | Kidney and liver function and albumin, which affect both the inflammatory response and how results are interpreted |
| Lipid panel | Cardiovascular context when high-sensitivity CRP has been ordered for risk assessment |
| HbA1c and fasting insulin | Metabolic context, since glucose regulation and body composition influence baseline inflammatory signalling |
| Thyroid markers | Fatigue and weight change workups, where a non-inflammatory explanation is on the list |
This is the reasoning behind panel based testing generally. One marker gives a reading. Several markers give a pattern, and patterns are far harder to misread. FitScript tests 150+ biomarkers per year and Atlas, its AI health advisor, interprets them in the context of a member's history, with a licensed provider deciding on any care that follows.
Because CRP moves fast, and movement is the most informative thing about it. The liver raises output soon after an inflammatory stimulus and lowers it as the stimulus resolves, so two measurements separated by days describe a process that one measurement cannot 2.
A repeat answers several questions at once. Is this an acute event that is now resolving, or something sustained? Was the first value a blip from a minor illness or a hard workout? Is the picture improving at the pace expected after surgery or an identified infection? Is a mildly raised value in an otherwise well person reproducible, or did it disappear on retesting?
For high-sensitivity CRP the reasoning is slightly different. There, the point of a repeat is to establish a stable baseline, free of the acute noise that any recent illness or injury introduces. A single low-end value taken during an unremarkable week is a weak basis for a long term risk estimate. Two consistent values taken when well are stronger.
How long to wait between draws depends entirely on what is being followed, and is set by the clinician rather than by a general rule. Asking when the repeat should happen, and what would count as an expected trend, is one of the more useful questions to raise at the appointment.
The clinician places the number next to everything else they know and decides what it changes. The useful way to think about any CRP result is in three steps, observation, possible meaning, and next step.
The observation is the value itself and how it compares with your own previous results. The possible meaning is deliberately plural. A raised value may reflect an active infection, recent tissue injury or surgery, an inflammatory condition, or a background level of low grade inflammation related to lifestyle and body composition. A value within range may reflect the absence of a strong systemic inflammatory response, or simply that the process involved does not produce one.
The next step is where the clinician decides. That might be a repeat in a defined interval, a broader panel, imaging, cultures, a referral, or a review of sleep, training load, body composition and nutrition. It might also be no action at all, with a note to recheck at the next review. Where any prescribed therapy is considered, a licensed provider evaluates whether it is appropriate after reviewing the whole picture, not a single marker.
What should not happen is a diagnosis being read off one number, in either direction. A normal CRP does not close an investigation that symptoms keep open, and a mildly raised CRP in a well person is not a condition.
When the number is markedly raised, when it is climbing on repeat testing, or when it arrives alongside symptoms that are themselves concerning. High fever, severe or localised pain, breathlessness, confusion, a rapidly worsening wound, or feeling significantly more unwell than the day before are all reasons to seek care promptly rather than wait for the next appointment, whatever the lab value says.
An unexpectedly raised value in someone who feels well is a different situation. It is still worth discussing, because it usually calls for a repeat and a short conversation about recent illness, injury, training and sleep. The common outcome is a normal repeat and a simple explanation. The point of the conversation is to make sure the uncommon outcome is not missed.
Never ignore a result that sits outside your lab's reference range, and never assume a result within range rules out a problem you can feel. This page is educational and is not medical advice. Discuss your own results, and any decisions about care, with your clinician or a licensed provider who can see your full history.
No. A raised CRP shows that an inflammatory response is active, and infection is only one of the things that can cause it. Injury, recent surgery, dental problems, an inflammatory condition and ordinary recovery from hard exercise can all lift the number. Your clinician reads the value alongside your symptoms, examination and other tests before drawing any conclusion.
Usually not for CRP itself, since it is measured from a standard blood sample and does not require fasting in most labs. You may still be asked to fast if other markers are being drawn at the same time, such as glucose or a lipid panel. Follow the instructions given with your request form, and ask the lab if you are unsure.
Both measure the same protein. The high-sensitivity version uses an assay that reads accurately at very low concentrations, where the standard test simply reports a value below its floor. Standard CRP is used when an acute problem is suspected or followed. High-sensitivity CRP is used for longer term risk context in someone who is not currently unwell.
Yes. A minor infection, a dental problem, an injury or an unusually hard training session can all raise CRP temporarily. That is fine when the test is looking for an acute problem, but it blurs the picture when a high-sensitivity result is being used for long term risk context. If you have been ill or trained very hard recently, mention it before the draw.
No. Some processes are localised, slow moving, or simply do not produce a strong whole-body response, so a value inside the reference range does not rule them out. Timing matters too, because a sample taken very early in an illness can be drawn before levels have risen. Persistent symptoms deserve follow-up even when the number looks fine.
A low result is generally unremarkable and is what most lab reports describe as being within range. There is no established benefit to worrying about a value at the bottom of the scale. The interpretation that matters is whether your result fits your symptoms and your previous values, which is a question for the clinician who ordered the test.
That depends entirely on what is being followed. A suspected acute problem may be rechecked within days, a monitored condition over weeks or months, and a high-sensitivity result on a separate occasion when you are well. There is no universal interval, so ask what trend your clinician expects to see and when the next draw should happen.
Your clinician does, working from the result plus your history, examination and any other markers. The next step may be a repeat test, a wider panel, imaging, a referral, or a review of sleep, training, body composition and nutrition. Where any prescribed therapy is considered, a licensed provider evaluates whether it is appropriate for you.